Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

Journal of Infectious Diseases

Volumn 173, Issue 4, 1996, Pages 1014-1018

  Powers, Douglas C ^a   Anderson, Edwin L ^b   Lottenbach, Kathleen ^b   Mink, Chrisanna M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; OLIGOSACCHARIDE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; IMMUNOGENICITY; INJECTION PAIN; MALE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0030051692     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.4.1014     Document Type: Article

References (15)

1. Advisory Committee on Immunization Practices. Pneumococcal polysaccharide vaccine. MMWR 1989;38:64-8,73-6.
2. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14:801-9.
3. Roghmann KJ, Tabloski PA, Bentley DW, Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol 1987;42:265-70.
4. Dintzis RZ. Rational design of conjugate vaccines. Pediatr Res 1992;32:376-85.
5. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzas type b conjugate vaccines. J Infect Dis 1993;168:663-71.
6. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
7. Eby R, Koster M, Hogerman D, Malinoski F. Pneumococcal conjugates. In: Norrby E, Brown F, Chanock RM, Ginsberg HS, eds. Vaccines 94: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994:119-24.
8. Manclark CR, Meade BD, Burstyn DG. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology. 3rd ed. Washington, DC: American Society for Microbiology, 1986:388-4.
9. Insel R, Munoz J, Etzel K, Anderson P. Ontogeny of human antibody responses to bacterial capsular polysaccharides. In: Robbins JB, Schneerson R, Klein D, Sadoff J, Hardegree MC, eds. Bacterial vaccines. New York: Praeger, 1987:41-51.
10. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981;3(suppl):S184-96.
11. Steinhoff MC, Edwards K, Keyserling H, et al. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 1994;13:368-72.
12. Fattom A, Lue C, Szu SC, et al. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun 1990;58:2309-12.
13. Granoff DM, Powers D, Moore S, Mink CM. Vaccination of elderly adults with Haemophilus influenzae type b (Hib) polysaccharide or conjugate vaccine [abstract G76]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
14. Lucas AH, Granoff DM, Vaccine Study Group. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type b polysaccharide-protein conjugates. J Immunol 1995;154:4195-202.
15. Granoff DM, Shackelford PG, Holmes SJ, Collaborative Vaccine Study Group, Lucas AH. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates: description of a new light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. J Clin Invest 1993;91:788-96.